InvestorsHub Logo
Followers 10
Posts 3101
Boards Moderated 0
Alias Born 10/01/2004

Re: Major_Bankz post# 4382

Monday, 01/30/2006 5:43:00 PM

Monday, January 30, 2006 5:43:00 PM

Post# of 49475
New Insulin Drugs in Vogue
http://press.namct.com/content/view/5360/139/

After Pfizer (NYSE: PFE) released premature information on live television last week about an FDA approval, later that day they did indeed receive approval for their inhaled insulin treatment called Exubera,, this was approved for adults with either Type 1 or Type 2 diabetes. Analyst estimate that this could bring in sales of upwards of $1 billion to Pfizer. On that note lets talk about a little known company called Generex Biotechnology Corp (NASDAQ: GNBT), it’s a Canadian drug delivery technology company that is in talks with Health Canada's Biologics and Genetic Therapies Directorate for marketing clearance of Oral-lyn oral insulin spray, it’s a form of insulin that is absorbed in the mouth. We featured Generex on the NAMC Newswire a few weeks ago and in light of the new Pfizer FDA approval we felt it was necessary to mention the company again. They are at the right place at the right time, with the right product. So Generex Biotech is one company to look at.



THE THRILL OF VICTORY ;-) & THE AGONY OF DEFEAT ;-(

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.